scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1016257982 |
P356 | DOI | 10.1245/S10434-011-2125-1 |
P932 | PMC publication ID | 3884694 |
P698 | PubMed publication ID | 22048633 |
P2093 | author name string | James R Goldenring | |
Min-A Kim | |||
Han-Kwang Yang | |||
Woo Ho Kim | |||
Hyuk-Joon Lee | |||
Ki Taek Nam | |||
Yun-Suhk Suh | |||
Eun-Jung Jung | |||
P2860 | cites work | Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells | Q24291012 |
A novel gene activated in regenerating islets | Q24294417 | ||
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma | Q27824784 | ||
A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
Gene-expression profiles predict survival of patients with lung adenocarcinoma | Q29614443 | ||
Use of a cDNA microarray to analyse gene expression patterns in human cancer | Q29618814 | ||
Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies | Q30724668 | ||
Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications | Q31059425 | ||
Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. | Q32061478 | ||
A molecular signature of gastric metaplasia arising in response to acute parietal cell loss | Q33317849 | ||
Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer | Q33557996 | ||
Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia | Q33750475 | ||
Intestinal cell adhesion molecules. Liver-intestine cadherin | Q33934218 | ||
Clinical significance of dysadherin expression in gastric cancer patients | Q34315548 | ||
Inactivation of the E-cadherin-mediated cell adhesion system in human cancers | Q35753235 | ||
Galectin-4 in normal tissues and cancer | Q35759428 | ||
Expression of the cell-cell adhesion glycoprotein cell-CAM 120/80 in normal human tissues and tumors. | Q35817618 | ||
The galectin family and digestive disease | Q37108003 | ||
Role of DNA methylation in the development of diffuse-type gastric cancer | Q37832910 | ||
Galectins as cancer biomarkers | Q38105320 | ||
Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer | Q39651684 | ||
The role of Reg IV gene and its encoding product in gastric carcinogenesis | Q39801619 | ||
Molecular mechanisms of cell adhesion in normal and transformed cells | Q39819944 | ||
Reg IV enhances peritoneal metastasis in gastric carcinomas | Q39895385 | ||
Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy | Q40180989 | ||
Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma | Q40387409 | ||
Overexpression of MUC13 is associated with intestinal-type gastric cancer | Q40420359 | ||
De-novo expression of CD44 and survival in gastric cancer | Q42483834 | ||
Tumour suppressor gene expression correlates with gastric cancer prognosis | Q44401645 | ||
Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. | Q50505727 | ||
Japanese Classification of Gastric Carcinoma - 2nd English Edition - | Q51050338 | ||
Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. | Q51597657 | ||
Expression profile of REG family proteins REG Ialpha and REG IV in advanced gastric cancer: comparison with mucin phenotype and prognostic markers. | Q51746168 | ||
Protein expression profiling and molecular classification of gastric cancer by the tissue array method. | Q51910260 | ||
Increased incidence of undifferentiated type of gastric cancer with tumor progression in 912 patients with early gastric cancer and 1245 with advanced gastric cancer. | Q53472187 | ||
Molecular mechanism of stomach carcinogenesis. | Q53483428 | ||
Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. | Q54469747 | ||
E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration | Q70611377 | ||
Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer | Q73592530 | ||
Molecular characterization of undifferentiated-type gastric carcinoma | Q73757919 | ||
MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators | Q77357135 | ||
Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma | Q81249390 | ||
P433 | issue | 4 | |
P921 | main subject | biomarker | Q864574 |
P304 | page(s) | 1240-1249 | |
P577 | publication date | 2011-11-03 | |
P1433 | published in | Annals of Surgical Oncology | Q2853069 |
P1476 | title | The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer | |
P478 | volume | 19 |
Q36677718 | Cadherin-17 induces tumorigenesis and lymphatic metastasis in gastric cancer through activation of NFκB signaling pathway |
Q26783991 | Correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancer |
Q47759471 | Differential expression of two genes Oct-4 and MUC5AC associates with poor outcome in patients with gastric cancer |
Q39500994 | Effects of Helicobacter pylori infection on MUC5AC protein expression in gastric cancer |
Q38841122 | Epigenetic silencing of olfactomedin-4 enhances gastric cancer cell invasion via activation of focal adhesion kinase signaling |
Q31125021 | Gene expression analysis of a Helicobacter pylori-infected and high-salt diet-treated mouse gastric tumor model: identification of CD177 as a novel prognostic factor in patients with gastric cancer |
Q49361058 | Long non-coding RNA CAT104 promotes cell viability, migration and invasion in gastric carcinoma cells through activation of microRNA-381 inhibiting zinc finger E-box binding homeobox 1 (ZEB1) expression |
Q36131557 | Methylation-dependent activation of CDX1 through NF-κB: a link from inflammation to intestinal metaplasia in the human stomach |
Q38268568 | Olfactomedin-4 is a candidate biomarker of solid gastric, colorectal, pancreatic, head and neck, and prostate cancers. |
Q41673477 | Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer |
Q36186928 | Overexpression of Plasminogen Activator Inhibitor-1 in Advanced Gastric Cancer with Aggressive Lymph Node Metastasis |
Q57280332 | PTK7 as a novel marker for favorable gastric cancer patient survival |
Q51029933 | Plasma expression of the intestinal metaplasia markers CDH17 and TFF3 in patients with gastric cancer. |
Q49527958 | Plasma olfactomedin 4 level in peripheral blood and its association with clinical features of breast cancer |
Q36085609 | Prognostic value of Muc5AC in gastric cancer: A meta-analysis |
Q36355626 | Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers |
Q36529179 | Single nucleotide polymorphisms in the CDH17 gene of colorectal carcinoma |
Q28543901 | Upregulation of autophagy-related gene-5 (ATG-5) is associated with chemoresistance in human gastric cancer |
Search more.